GlyTech, Inc.

NEWS&TOPICS

Oct 12, 2017 [News Release]

GlyTech, Inc. to Present at the 6th Modern Solid Phase Peptide Synthesis & Its Applications Symposium

GlyTech, Inc. is scheduled to present at the 6th Modern Solid Phase Peptide Synthesis & Its Applications Symposium to be held in Australia on October 12-14th 2017.

6th Modern Solid Phase Peptide Synthesis & Its Applications Symposium

Apr 14, 2017 [News Release]

GlyTech, Inc. to Deliver a Lecture at a Seminar Held by Technical Information Institute Co. Ltd.

GlyTech, Inc. is scheduled to deliver a lecture at a seminar on the "Enhancement of Permeability, Absorbability, and Stability of Peptide Drugs" to be held by Technical Information Institute Co. Ltd. on April 14th 2017 in Tokyo.

The lecture will present how N-linked glycan modification dramatically improves the stability of peptides/proteins in the blood, while also increasing their solubility and significantly decreasing their aggregation and immunogenicity.

Mar 26, 2017 [News Release]

GlyTech, Inc. to Present at the 137th Annual Meeting of the Pharmaceutical Society of Japan (Sendai)

GlyTech, Inc. is scheduled to make an oral presentation and a poster presentation at the 137th Annual Meeting of the Pharmaceutical Society of Japan in Sendai on March 26th 2017.

The 137th Annual Meeting of the Pharmaceutical Society of Japan

Feb 10, 2017 [News Release]

GlyTech, Inc. to Exhibit at the 14th Business Link Shobai Hanjo at PACIFICO Yokohama

GlyTech, Inc. is scheduled to exhibit in the Open Innovation area at the 14th Business Link Shobai Hanjo to be held by MUFG Bank Ltd. in Yokohama on February 10th 2017.

Oct 31, 2016 [News Release]

GlyTech, Inc. to Deliver a Lecture at a Seminar Held by BB-Bridge Inc.

GlyTech, Inc. (CEO: Mr. Hiroaki Asai) is scheduled to deliver a lecture at a seminar on the development of biopharmaceuticals to be held by Technical Information Institute Co. Ltd. in Tokyo on October 31st 2016.

The lecture will present a new DDS technology for biopharmaceuticals based on glycosylation as a chemical modification technology for active proteins.

Seminar on Biopharmaceuticals Development

Oct 22, 2016 [News Release]

GlyTech, Inc. to Present at the 3rd FCCA Symposium/Forum of Young Glycoscientists 2016

GlyTech, Inc. is scheduled to make an oral presentation on the formation of biopharmaceuticals based on N-linked glycan modification technology at the 3rd FCCA Symposium/Forum of Young Glycoscientists 2016 in Hiratsuka on October 22nd 2016.

The 3rd FCCA Symposium/Forum of Young Glycoscientists 2016

Oct 12, 2016 [News Release]

GlyTech, Inc. to Exhibit at BioJapan 2016

GlyTech, Inc. is scheduled to exhibit in the JBA Biotech Square (Bio Venture Co-exhibition Pavilion) at BioJapan 2016, which is to be held in Yokohama from October 12–14th 2016.

Sep 25, 2016 [News Release]

GlyTech, Inc. to Present at the 89th Annual Meeting of the Japanese Biochemical Society (Sendai)

GlyTech, Inc is scheduled to make an oral presentation and poster presentation on the effect of manganese ion replenishment on the production of human-core type-3 glycans using yeast at the 89th Annual Meeting of the Japanese Biochemical Society (Sendai), which is to be held in Sendai on September 26-27th 2016.

Sep 1, 2016 [News Release]

An article by GlyTech, Inc. is to be published in the Sep 2016 issue of Medical Science Digest

An article by GlyTech, Inc. on the chemical formation and manufacturing of biopharmaceuticals is to be published in the September 2016 issue of Medical Science Digest by Hokuryukan Co. Ltd.

Aug 25, 2016 [News Release]

GlyTech, Inc. to Exhibit at Innovation Japan 2016

GlyTech, Inc. is scheduled to exhibit at the University Trade Fair & Business Matching Event at Innovation Japan 2016, which is to be held in Tokyo from August 25-26th 2016.

The exhibit will present glycan modification technology for the innovation of biopharmaceuticals and the formation of somatostatin analogs.

Apr 25, 2016 [News Release]

GlyTech, Inc. to Receive Excellent Company Award from the 3rd BTMU Business Support Program "Rise Up Festa"

GlyTech, Inc. has been selected to receive an Excellent Company Award from the 3rd BTMU Business Support Program "Rise Up Festa".

Backed by MUFG Bank, the "Rise Up Festa" support program targets companies in 4 industries with potential for future growth that are working on a new business with a global market in mind.

Award winning companies will be able to receive a variety of assistance to facilitate their growth, including financial backing and consulting and business matching services.

The Award Winning Companies for the 3rd BTMU Business Support Program "Rise Up Festa" Have Been Announced

Feb 24, 2016 [News Release]

Announcement of Publication of Article on Glycans

GlyTech, Inc. is pleased to announce that an international joint research group, including Chief Scientist Katsunori Tanaka of the Biofunctional Synthetic Chemistry Laboratory at RIKEN (Institute of Physical and Chemical Research), have clusterized GlyTech "asparagine-linked glycans (N-linked glycan)" of various structures attached to albumin, and managed to control their elimination route inside mice. Additionally, the resulting glycoclusters were found to show high specificity for particular liver cells. Their findings have been published in Scientific Reports, a British online scientific journal (February 23).

[ Press Release by Riken (Feb 23) ] "Glycan Complexes With High Cellular Specificity in Living Bodies"

Announcement of Publication of Article on Glycans

Oct 14, 2015 [ NewsRelease ]

Nippon Shokubai and GlyTech Announce to Collaborate on R&D and Nippon Shokubai Subscribe for Shares of GlyTech through Third Party Allotment.

NIPPON SHOKUBAI CO., LTD. (Headquarter: Osaka, Japan, President: Masanori Ikeda, hereinafter “Nippon Shokubai”) and GlyTech, Inc. (Headquarter: Kyoto, Japan, President: Hiroaki Asai, hereinafter “GlyTech”) announce that they have agreed to collaborate on research and development of Glycosylated Somatostatin Analog (hereinafter “G-SRIF”). Based on this agreement with GlyTech, Nippon Shokubai has decided to establish a laboratory of peptide API (active pharmaceutical ingredient) synthesis.

Nippon Shokubai and GlyTech Announce to Collaborate on R&D and Nippon Shokubai Subscribe for Shares of GlyTech through Third Party Allotment.

Jan 10, 2015 [ NewsRelease ]

An article written by GlyTech's CEO Hiroaki Asai and Dr. Izumi Sakamoto
was published in the 31th issue of PHARM TECH JAPAN (No. 1, p119-121).

An article "Oligosaccharide structures and Biopharmaceuticals Part 1" written by GlyTech's Hiroaki Asai and Izumi Sakamoto was published in the 30th issue of PHARMA TECH JAPAN. PHARM TECH JAPAN is known for presenting on the latest ideas, cutting-edge technologies and innovationas covering not only drug manufacturing but also the regulatory issues.

PHARM TECH JAPAN Homepage

Link to 30th Isuue of PHARM TECH JAPANN

Dec 10, 2014 [ NewsRelease ]

An article written by GlyTech's CEO Hiroaki Asai and Dr. Izumi Sakamoto
was published in the 30th issue of PHARM TECH JAPAN (No. 14, p57-60).

An article "Oligosaccharide structures and Biopharmaceuticals Part 1" written by GlyTech's Hiroaki Asai and Izumi Sakamoto was published in the 30th issue of PHARM TECH JAPAN. PHARM TECH JAPAN is known for presenting on the latest ideas, cutting-edge technologies and innovationas covering not only drug manufacturing but also the regulatory issues.

PHARM TECH JAPAN Homepage

Link to 30th Isuue of PHARM TECH JAPANN

Dec 9, 2014 [ NewsRelease ]

An article written by Dr. Izumi Sakamoto was published in the 30th issue
of PHARM TECH JAPAN (No. 11, p61-64).

An article "Chemically synthesized glycoproteins shed light on novel analytical technologies for biopharmaceuticals" written by Acroscale's Izumi Sakamoto was published in the 30th issue of PHARM TECH JAPAN. PHARM TECH JAPAN is known for presenting on the latest ideas, cutting-edge technologies and innovationas covering not only drug manufacturing but also the regulatory issues.

PHARM TECH JAPAN Homepage

Link to 30th Isuue of PHARM TECH JAPANN

Acloscale, Inc. is a wholly owned subsidiary of GlyTech, Inc. and founded in 2014 to develop QC methods for chemically synthesized glycoproteins and the related molecules and offer its analytical services.

Acloscale Homepage (Japanese only)

Oct 8, 2014 [ NewsRelease ]

Luncheon seminar with GlyTech, Inc. at the 51st Japanese Peptide Symposium

Kyoto (Japan), 8th October 2014 – GlyTech, Inc. is scheduled to host a luncheon seminar at the 51st Japanese Peptide Symposium, Japan to be held Oct 22-24, 2014 in Tokushima, Japan.

Luncheon seminar with GlyTech, Inc. at the 51st Japanese Peptide Symposium

Oct 7, 2014 [ NewsRelease ]

Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement

Bachem AG (Bubendorf, Switzerland), the leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), the world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing resources to enhance GlyTech’s partnering efforts and GlyTech will promote Bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins.

Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement

Oct 7, 2014 [ NewsRelease ]

American Peptide Company and GlyTech, Inc. Announce Co-promotion Agreement

American Peptide Company, Inc. (APC) (Vista, CA) a leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), a world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation technology. As part of the agreement, APC will leverage its sales and marketing resources to enhance GlyTech’s partnering efforts and GlyTech will promote APC as a partner of choice for manufacture of its glycopeptides and glycoproteins.

American Peptide Company and GlyTech, Inc. Announce Co-promotion Agreement.

Sep 1, 2014 [ NewsRelease ]

GlyTech, Inc. to Present at the 66th SBJ Annual Meeting 2014.

Kyoto (Japan), 1st September 2014 - GlyTech, inc. is scheduled to present at the 66th Annual Meeting of the Society for Biotechnology, Japan to be held Sep 9-11, 2014 in Sapporo, Japan.

GlyTech, Inc. to Present at the 66th SBJ Annual Meeting 2014.

Apr 30, 2014 [ NewsRelease ]

GlyTech, Inc. to Present at TIDES 2014

Kyoto (Japan), 30 April 2014 – GlyTech, Inc. is scheduled to present at TIDES 2014 to be held May 12-15, 2014 in Providence, US. During the presentation, an update regarding GlyTech’s technologies will be provided.

GlyTech to Present at TIDES 2014

Apr 09, 2014 [ NewsRelease ]

GlyTech to Present at PEGS (Protein EnGineering Summit) Boston

GlyTech is scheduled to present at PEGS Boston to be held May 5-9, 2014 in Boston, US. During the presentation, an update regarding GlyTech's technologies will be provided.

GlyTech to Present at PEGS (Protein EnGineering Summit) Boston

Jan 31, 2014 [ NewsRelease ]

GlyTech Secures 600 Million JPY in Series A Financing From Japanese Leading Venture Capital Firms

GlyTech Inc. (Kyoto, Japan), a world leading company of glycosylation, today announced that it has raised 600 million JPY in a Series A financing from four venture capital firms, the University of Tokyo Edge Capital Co. Ltd. (UTEC), DBJ Capital Co., Ltd., Mitsui Sumitomo Insurance Venture Capital and Mitsubishi UFJ Capital Co. Ltd.

GlyTech Secures 600 Million JPY in Series A Financing From Japanese Leading Venture Capital Firms

Oct 23, 2013 [ PressRelease ]

GlyTech and Bachem Named Finalist for CPhI Pharma Award for Best Innovation in Process Development.

Kyoto (Japan), 23 October 2013 – On 22th, October 2013 in Frankfurt, Germany, GlyTech and Bachem were selected as one of three finalists for the 2013 CPhI Pharma Award for Best Innovation in Process Development. Although not ultimately winning the award, being selected as a finalist represents significant validation of the value of the technology and collaboration. The award ceremony took place on the same day as part of the annual CPhI Worldwide exhibition, which attracted approximately 30,000 attendees from the pharmaceutical industry.

the 2013 CPhI Pharma Award

Aug 12, 2013 [ NewsRelease ]

Luncheon seminar with GlyTech, Inc. at the 32th Annual meeting of the Japanese Society of Carbohydrate Research

Kyoto (Japan), 12 August 2013 – On 6th, August 2013, Mr. Hiroaki Asai, CEO at GlyTech, Inc. gave a presentation which title was “Industrial applications of Glycans” at Luncheon Seminar hosted by Sumitomo Bakelite Co., Ltd. during the 32th Annual Meeting of the Japanese Society of Carbohydrate Research in Osaka, Japan.

Luncheon seminar with GlyTech, Inc. at the 32th Annual meeting of the Japanese Society of Carbohydrate Research(English)

Luncheon seminar with GlyTech, Inc. at the 32th Annual meeting of the Japanese Society of Carbohydrate Research(Japanese)

july 10, 2013 [ PressRelease ]

Pioneering breakthrough in the chemical synthesis of Interferon β-1a

Bachem and GlyTech achieved a pioneering breakthrough with the successful chemical synthesis of this protein featuring a specific, single glycosylation.

About Bachem
Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.

Pioneering breakthrough in the chemical synthesis of Interferon β-1a (135KB)